{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:41:23Z","timestamp":1792521683062,"version":"4.5.0"},"reference-count":35,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2020,10,3]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Cystic fibrosis (CF) is a recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. The gene product, CFTR protein, has important manifestations in the intestine, pancreas and hepatobiliary system. Increased survival has caused CF to be primarily an adult disease today. Physicians must be knowledgeable as to the varied phenotype in the gastrointestinal tract. This review will outline the main gastrointestinal manifestations including a section on gastrointestinal malignancy in CF. Novel treatments treating the basic effect in CF are now being introduced and their effects on the gastrointestinal tract are discussed.<\/jats:p>","DOI":"10.1136\/flgastro-2020-101610","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T17:25:24Z","timestamp":1603819524000},"page":"622-628","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Cystic fibrosis and the gut"],"prefix":"10.1136","volume":"12","author":[{"given":"Mordechai","family":"Slae","sequence":"first","affiliation":[{"name":"Paediatric Gastroenterology, Hadassah University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-5185","authenticated-orcid":false,"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[{"name":"Paediatric Gastroenterology, Hadassah University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"2025090708110988000_12.7.622.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043184"},{"key":"2025090708110988000_12.7.622.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.062786"},{"key":"2025090708110988000_12.7.622.3","first-page":"1178","article-title":"Genetic determination of exocrine pancreatic function in cystic fibrosis","volume":"50","author":"Kristidis","year":"1992","journal-title":"Am J Hum Genet"},{"key":"2025090708110988000_12.7.622.4","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37042"},{"key":"2025090708110988000_12.7.622.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.046"},{"key":"2025090708110988000_12.7.622.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000181474.08058.b3"},{"key":"2025090708110988000_12.7.622.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1295"},{"key":"2025090708110988000_12.7.622.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.033"},{"key":"2025090708110988000_12.7.622.9","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcf.2017.03.006","article-title":"Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension","volume":"16","author":"Witters","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2025090708110988000_12.7.622.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60129-X"},{"key":"2025090708110988000_12.7.622.11","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.cgh.2019.03.015","article-title":"Accuracy of transient elastography data combined with apri in detection and staging of liver disease in pediatric patients with cystic fibrosis","volume":"17","author":"Lewindon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090708110988000_12.7.622.12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcf.2011.08.002","article-title":"Ursodeoxycholic acid in cystic fibrosis-associated liver disease","volume":"11","author":"Ooi","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2025090708110988000_12.7.622.13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000371904","article-title":"Potential of nor-ursodeoxycholic acid in cholestatic and metabolic disorders","volume":"33","author":"Trauner","year":"2015","journal-title":"Dig Dis"},{"key":"2025090708110988000_12.7.622.14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.29217","article-title":"Adult-Onset cystic fibrosis liver disease: diagnosis and characterization of an underappreciated entity","volume":"66","author":"Koh","year":"2017","journal-title":"Hepatology"},{"key":"2025090708110988000_12.7.622.15","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2017.06.007","article-title":"Meconium ileus in cystic fibrosis","volume":"16","author":"Sathe","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2025090708110988000_12.7.622.16","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181a6e01d"},{"key":"2025090708110988000_12.7.622.17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcf.2016.02.002","article-title":"International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: associated factors and outcome","volume":"15","author":"Munck","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2025090708110988000_12.7.622.18","doi-asserted-by":"crossref","unstructured":"Wilschanski M . Uc a cystic fibrosis. in textbook of pediatric gastroenterology, hepatology and nutrition \u2013 a comprehensive guide to practice. Springer, 2015.","DOI":"10.1007\/978-3-319-17169-2_41"},{"key":"2025090708110988000_12.7.622.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.11.312"},{"key":"2025090708110988000_12.7.622.20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.21037\/tgh.2019.08.11","article-title":"Gastroesophageal reflux in cystic fibrosis across the age spectrum","volume":"4","author":"Woodley","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"2025090708110988000_12.7.622.21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025090708110988000_12.7.622.22","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181e2c6f8"},{"key":"2025090708110988000_12.7.622.23","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/onc.2015.483","article-title":"Cftr is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"key":"2025090708110988000_12.7.622.24","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/MCG.0000000000000034","article-title":"Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps","volume":"48","author":"Billings","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"2025090708110988000_12.7.622.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.12.012"},{"key":"2025090708110988000_12.7.622.26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(18)30250-X","article-title":"Cystic fibrosis: a gastrointestinal cancer syndrome","volume":"19","author":"Slae","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025090708110988000_12.7.622.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2025090708110988000_12.7.622.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"2025090708110988000_12.7.622.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2025090708110988000_12.7.622.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2025090708110988000_12.7.622.31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MPG.0000000000001868","article-title":"Cftr protein function modulation therapy is finally targeting cystic fibrosis-related gastrointestinal disease","volume":"66","author":"Bodewes","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090708110988000_12.7.622.32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (kiwi): an open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025090708110988000_12.7.622.33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"Ivacaftor treatment of cystic fibrosis in children aged 12 to","volume":"6","author":"Rosenfeld","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025090708110988000_12.7.622.34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0000000000001788","article-title":"Reduction of recurrence risk of pancreatitis in cystic fibrosis with ivacaftor: case series","volume":"66","author":"Carrion","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090708110988000_12.7.622.35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2020-101610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:11:21Z","timestamp":1757257881000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2020-101610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,11,23]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/flgastro-2020-101610"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2020-101610","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}